Trubion Pharmaceuticals, Inc (TRBN) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 104 transactions totaling $5.3M, demonstrating a bullish sentiment with $5.3M in net insider flow. The most recent transaction on Oct 28, 2010 involved a transaction of 15,947 shares valued at $0.
No significant insider buying has been recorded for TRBN in the recent period.
No significant insider selling has been recorded for TRBN in the recent period.
Based on recent SEC filings, insider sentiment for TRBN is bullish with an Insider Alignment Score of 100/100 and a net flow of $5.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Trubion Pharmaceuticals, Inc (TRBN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading TRBN stock, having executed 104 transactions in the past 90 days. The most active insider is Steven Gillis (Executive), who has made 4 transactions totaling $580.3K.
Get notified when executives and directors at TRBN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 28, 2010 | R. Brettman Lee | Executive | Disposition | 15,947 | $N/A | $0 | |
| Oct 28, 2010 | Gillis Steven | Executive | Disposition | 2,357,046 | $N/A | $0 | |
| Oct 28, 2010 | J. Heron Patrick | Executive | Disposition | 8,291 | $N/A | $0 | |
| Oct 28, 2010 | J. Heron Patrick | Executive | Disposition | 4,457 | $N/A | $0 | |
| Oct 28, 2010 | J. Heron Patrick | Executive | Disposition | 1,632,687 | $N/A | $0 | |
| Oct 28, 2010 | J. Heron Patrick | Executive | Disposition | 592,505 | $N/A | $0 | |
| Oct 28, 2010 | D. Hove Anders | Executive | Disposition | 1,512,111 | $N/A | $0 | |
| Oct 28, 2010 | D. Hove Anders | Executive | Disposition | 37,154 | $N/A | $0 | |
| Oct 28, 2010 | D. Hove Anders | Executive | Disposition | 308,367 | $N/A | $0 | |
| Oct 28, 2010 | A. Mann David | Executive | Disposition | 12,935 | $N/A | $0 | |
| Oct 28, 2010 | Mohler Kendall | Executive | Disposition | 140,206 | $N/A | $0 | |
| Oct 28, 2010 | Schnell David | Executive | Disposition | 27,866 | $N/A | $0 | |
| Oct 28, 2010 | Schnell David | Executive | Disposition | 1,829,765 | $N/A | $0 | |
| Oct 28, 2010 | IV Lp Frazier Healthcare | Executive | Disposition | 1,632,687 | $N/A | $0 | |
| Oct 28, 2010 | IV Lp Frazier Healthcare | Executive | Disposition | 8,291 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 48 | $5.3M | 99.3% |
Exercise(M) | 4 | $39.2K | 0.7% |
Disposition(D) | 17 | $0 | 0.0% |
Sale(S) | 3 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Conversion(C) | 30 | $0 | 0.0% |
Insiders at Trubion Pharmaceuticals, Inc are accumulating shares at an accelerated pace. With 27 insiders making 104 transactions totaling $5.3M in purchases versus $0 in sales, the net buying activity of $5.3M signals strong executive confidence. Steven Gillis (Executive) leads the buying activity with $580.3K in transactions across all time.